Matthew H Secrest

7PUBLICATIONS
22CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - proteins and peptides (incl. medical proteomics)Data mining and knowledge discoveryChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 14, 2025
Clinical Context Shapes the Relationship between Genomic Alterations and Response to AR Inhibitors and Chemotherapy in Metastatic Prostate Cancer.

Kalpit Shah, Matthew H Secrest, Wei Zhou

|Apr 20, 2022
Real-world treatment patterns and overall survival in BRAF-mutant melanoma patients treated with immunotherapy or targeted therapy.

Michael B Atkins, Cristina Julian, Matthew H Secrest

|Apr 13, 2020
Prevalence of pyruvate kinase deficiency: A systematic literature review.

Matthew H Secrest, Mike Storm, Courtney Carrington

|Sep 06, 2019
Multiple imputation for systematically missing confounders within a distributed data drug safety network: A simulation study and real-world example.

Matthew H Secrest, Robert W Platt, Pauline Reynier

|Aug 30, 2019
A population-based analysis of antidiabetic medications in four Canadian provinces: Secular trends and prescribing patterns.

Matthew H Secrest, Laurent Azoulay, Matthew Dahl

|Jan 11, 2019
Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research.

Matthew H Secrest, Robert W Platt, Colin R Dormuth

Pageof 2

Frequent Collaborators

1 joint publications

Robert W Platt

1 joint publications

Kristian B Filion

1 joint publications

Laurent Azoulay

1 joint publications

Madeleine Durand